Definitive Healthcare Corp.

NASDAQ:DH

Medical - Healthcare Information Services

Healthcare
$1.34 +1.85%

+$0.01 today

Market cap
$143.60M
Beta
1.33
P/E (TTM)
-0.5
EPS (TTM)
-$1.63
52W Low $0.77High $4.70

Volume 0.43M

Average 0.32M

DH Interest Income

Income earned on cash, deposits, and investments held by the company.

Definitive Healthcare Corp.NASDAQ: DH

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income declines year over year

Q1 FY2026 interest income of $1.3M fell 36.8% year over year, ahead of the -51.3% change in trailing-twelve-month interest income. Sequentially, it fell 12.5% from the prior quarter. Over 3 fiscal years it compounded at +35.6% a year.

Context

  • Interest income amounted to 2.9% of revenue in FY2025, down 2.9 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -36.8% holds above the trailing-twelve-month pace of -51.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.3M-12.5% QoQ
Last fiscal yearDec 2025
$6.95M-52.4% YoY
LTMMar 2026
$6.2M-51.3% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-36.8%——
1 year-52.4%——
3-year CAGR+35.6%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
6.95M USD
Year-over-year change
-52.4%
4-year CAGR
+293.5%

Interest Income vs competitors

How DH compares with its peers on the latest reported figures

  • DH's LTM Mar 2026 interest income of $6.2M is the 2nd highest of the 10 companies compared; the peer median is $775K.
  • Its year-over-year change of -51.3% is the 5th highest of 8, against a peer median of -44.4%.
  • Interest income amounts to 2.6% of revenue for DH, versus a peer median of 0.6%.
DH Competitors Peer median
Interest Income for DH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KYTXKyverna Therapeutics, Inc.LTM Mar 2026$8.6M -44.4%+152.5%—
DHDefinitive Healthcare Corp.LTM Mar 2026$6.2M -51.3%+35.6%2.6%
CABACabaletta Bio, Inc.LTM Mar 2026$5.62M -34.1%+73.0%—
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$1.71M -51.9%+12.2%2.1%
SLPSimulations Plus, Inc.LTM Feb 2026$964K -52.9%+0.2%1.2%
SPOKSpok Holdings, Inc.LTM Mar 2026$775K -30.7%+11.5%0.6%
NRCNational Research CorporationLTM Mar 2026$127K +27.0%-12.9%0.1%
TBRGTruBridge, Inc.LTM Mar 2026$0 ——0.0%
NAKANakamoto Inc.LTM Mar 2026$0 ——0.0%
EDITEditas Medicine, Inc.LTM Mar 2026-$1.51M -112.9%+14.6%3.9%
Peer median (excluding DH) $775K-44.4%+12.2%0.6%

Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue166.15M222.65M251.42M252.2M241.52M
Cost of Revenue40.69M42.63M47.48M54.73M58.25M
Gross Profit125.47M180.03M203.93M197.47M183.28M
Gross Margin75.5%80.9%81.1%78.3%75.9%
Research & Development18.57M34.89M42.44M36.52M34.78M
Selling, General & Admin89.25M141.15M153.4M133.07M133.26M
Operating Expenses152.78M224.07M533.73M908.29M203.86M
Depreciation & Amortization59.95M56.9M51.75M51.67M35.82M
EBITDA23.08M26.23M(241.23M)(567.24M)(162.15M)
EBITDA Margin13.9%11.8%-95.9%-224.9%-67.1%
Operating Income(27.32M)(44.04M)(329.8M)(710.82M)(20.58M)
Operating Margin-16.4%-19.8%-131.2%-281.8%-8.5%
Interest Income29K2.79M13.64M14.59M6.95M
Interest Expense25.9M11.2M15.2M14.84M11.29M
Other Income / Expenses(35.45M)2.17M21.62M77.08M(188.67M)
Income Before Tax(62.77M)(41.88M)(308.18M)(633.75M)(209.26M)
Pre-Tax Margin-37.8%-18.8%-122.6%-251.3%-86.6%
Income Tax Expense(443K)(17.7M)(18.55M)(42.3M)(9.96M)
Net Income(51.91M)(7.22M)(202.39M)(413.12M)(138.93M)
Net Margin-31.2%-3.2%-80.5%-163.8%-57.5%
EPS (Basic)(0.19)(0.07)(1.79)(3.54)(1.30)
EPS (Diluted)(0.19)(0.07)(1.79)(3.54)(1.30)
Weighted Avg Shares97.03M101.11M112.76M116.64M106.65M
Weighted Avg Shares (Diluted)97.03M101.11M112.76M116.64M106.65M

Definitive Healthcare Corp.

NASDAQ:DH

Intrinsic Alpha fair value

Locked

Current Price

$1.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.